We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A year of novel pharmacologic agents in review.
- Abstract
The article provides information on novel pharmacologic agents in the U.S. The pharmacologic agents include the posaconazole drug developed by Schering-Plough Corp., the cilansetron drug from Solvay Pharmaceuticals Inc., and the ramelteon drug developed by Takeda Pharmaceuticals Co. Ltd. Posaconazole is a triazole antifungal agent for the treatment of invasive fungal infections. Cilansetron is a receptor antagonist for the treatment of irritable bowel syndrome, while ramelteon is a melatonin receptor agonist for the treatment of insomnia.
- Subjects
UNITED States; DRUGS; DRUG development; SCHERING-Plough Corp.; SOLVAY Pharmaceuticals Inc.; TAKEDA Pharmaceutical Co. Ltd.; ANTIFUNGAL agents; CHEMICAL inhibitors
- Publication
Formulary, 2005, Vol 40, Issue 11, p382
- ISSN
1082-801X
- Publication type
Article